Revolution Medicines (RVMD) Asset Writedowns and Impairment (2024)
Revolution Medicines' (RVMD) quarterly Asset Writedowns and Impairment came in at $2.8 million in Q1 2024.
Revolution Medicines (RVMD) Asset Writedowns and Impairment (2024) Analysis & Trends
Revolution Medicines' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $2.8 million for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 37.23 Bn | 37.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.76 Mn |
| Mar 31, 2024 | 2.76 Mn |